TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06564701

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Roger TouchScreen Microphone
Description: Transmitter microphone system operating on the 2.4 GHz band, which allows for low-delay and reliable long-range broadcast to a compatible Roger receiver, designed to be used in educational settings. It features six microphones and adaptive technology in which speech signals are increased when background noise increases to ensure that the speech signal is always above the noise level.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Roger TouchScreen Microphone
Description: Transmitter microphone system operating on the 2.4 GHz band, which allows for low-delay and reliable long-range broadcast to a compatible Roger receiver, designed to be used in educational settings. It features six microphones and adaptive technology in which speech signals are increased when background noise increases to ensure that the speech signal is always above the noise level.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Partner Mic
Description: Wireless microphone that uses Phonak proprietary AirStream technology to connect to Phonak hearing aids. It uses a fixed directional microphone, and is paired to the hearing aids such that the hearing aid microphones are attenuated at a fixed level when the microphone is in use.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Partner Mic
Description: Wireless microphone that uses Phonak proprietary AirStream technology to connect to Phonak hearing aids. It uses a fixed directional microphone, and is paired to the hearing aids such that the hearing aid microphones are attenuated at a fixed level when the microphone is in use.
Study: NCT05359211

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lisocabtagene Maraleucel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-ray imaging

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy and aspiration

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow biopsy and aspiration

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Puncture
Description: Undergo LP

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study: NCT05100303

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride liposome injection
Description: Mitoxantrone hydrochloride liposome will be administered by intravenous (IV) injections.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine (LoDAC)
Description: Low-dose or high-dose cytarabine (LoDAC) will be administered by intravenous (IV) injections.
Study: NCT04648657

Intervention type: DEVICE
Intervention: Lung Ultrasound
Description: Echography of Lungs based on artifacts study

Intervention type: DEVICE
Intervention: Electric impedance tomography
Description: Low alternating electrical currents (usually \<5 milliampere at 50-80 kHz) applied through different pair of electrodes on thorax
Study: NCT06314360

Intervention type: OTHER
Intervention: No intervention.
Description: There is no intervention in this study.

Intervention type: OTHER
Intervention: No intervention.
Description: There is no intervention in this study.
Study: NCT05369143

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic care
Description: The mechanical properties of chiropractic adjustment have been investigated; and although the actual force applied to the patient's spine depends on the chiropractor, the patient, and the spinal location of the subluxation, the general shape of the force-time history of spinal adjustments is very consistent68 and the duration of the thrust is always less than 200 milliseconds.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group
Description: The participants head and/or spine will be moved in ways that include passive and active movements, similar to what is done when assessing the spine by a chiropractor. The sham intervention will also include the participants moving into adjustment setup positions similar to how the chiropractor would typically set up a patient with no joint pre-loading or adjustive thrust
Study: NCT05743777

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 400 mg IV q6 weekly for a maximum of 18 cycles

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: 400 mg IV q6 weekly for a maximum of 18 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MET-4
Description: Cycle 1: 5 g (10 capsules) on days -7 and -6 and 1.5 g (3 capsules) on day -5 and every day thereafter Cycle 2 onwards: 1.5 g (3 capsules) daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Cycle 1: 5 g (10 capsules) on days -7 and -6 and 1.5 g (3 capsules) on day -5 and every day thereafter Cycle 2 onwards: 1.5 g (3 capsules) daily
Study: NCT05926141

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACE intervention
Description: Participants attend the ACE Program for 12 weeks after school. On one assigned day of the week, participants attend ACE in person after school. The session begins with mindfulness exercises (15 minutes), professional development session (50 minutes), nutrition education lesson (20 minutes), and reflection period to talk about their experience in cooking lessons (25 minutes). On any day during the week, the students will make a dish using groceries they received (1 hour).
Study: NCT05951361

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 980nm Diode Laser
Description: 300 mW, 4 J/cm2, 2mm non-contact mode up to 10 sessions

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.1% topical triamcinolone Acetonide preparation Kenacourt-A Orabase
Description: three times daily for 4 weeks
Study: NCT05515484

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prone position with airbags
Description: prone position with airbags

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: prone position without airbags
Description: prone position without airbags
Study: NCT06501599

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)

Intervention type: DIAGNOSTIC_TEST
Intervention: Medical software (AI-based system)
Description: Retrospective analysis of chest CT images with medical software (AI-based system)
Study: NCT05890014

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich diet
Description: Inclusion of foods rich in flavonoids.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich diet
Description: Inclusion of foods rich in flavonoids.
Study: NCT04200183

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iACTwithPain (ACT+compassion)
Description: This intervention will deliver a eHealth ACT and compassion-based therapy (iACTwithPain) designed for chronic pain

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT-only intervention
Description: This intervention will deliver the iACTwithPain intervention but without the delivery of explicit compassion.
Study: NCT05924841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-B01D1
Description: Administration by intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B003
Description: Administration by intravenous infusion
Study: NCT05718440

Intervention type: OTHER
Intervention: Individualisation of uronephrological complications risk factors
Description: description of pelvic disorders in terms of clinical presentation, electrophysiology/urodynamics/anorectal manometry patterns, urethrocystography/urinary ultrasound/defecography results and urinary complications (infections, vesicoureteral reflux), depending on the dysraphim's type and level of injury and to correlate these parameters to the uronephrological risk factors and complications recorded.
Study: NCT05013580

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided bone regeneration (GBR)
Description: Bone grafts will be placed in the patient's jawbone, along with a membrane to cover the bone grafts. A horizontal incision over the edentulous ridge crest will be made along with vertical incisions if indicated. Buccal and lingual full thickness mucoperiosteal flaps will be reflected to expose the alveolar bone. Intra-marrow penetration (decortication of the alveolar bone to increase vascular supply to the bone grafts) at the surgical site alveolar bone will be made with a high-speed hand piece and diamond bur. Bone allograft material will be placed to fill the alveolar bone defect. The bone graft will then be covered with a membrane and secured with sutures.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR)
Description: Bone grafts will be placed in the patient's jawbone, along with a membrane to cover the bone grafts. A horizontal incision over the edentulous ridge crest will be made along with vertical incisions if indicated. Buccal and lingual full thickness mucoperiosteal flaps will be reflected to expose the alveolar bone. Intra-marrow penetration (decortication of the alveolar bone to increase vascular supply to the bone grafts) at the surgical site alveolar bone will be made with a high-speed hand piece and diamond bur. Bone allograft material will be placed to fill the alveolar bone defect. The bone graft will then be covered with a membrane and secured with sutures.
Study: NCT06461689

Intervention type: DRUG
Intervention: 177Lu-PSMA-617
Description: All patients treated with 177Lu-PSMA had a post-therapy 68Ga-PSMA PET scan and a post-therapy 177Lu-PSMA-617 SPECT/CT scan. These scans are available in the CHRU PACS, and patients are informed that their data may be used for research purposes, via posters in the nuclear medicine department or via the welcome booklet,
Study: NCT06231134

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional surgery
Description: an implant will be exposed using the conventional surgical exposure techniques with a tissue punch, the cover screw will be removed, and the healing abutment placed

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diode laser 940 nm
Description: implant will be uncovered using a diode laser (940nm) in contact type with a continuous mode at a power of 1.5 watts, the laser tip will be used in a circular motion to create a small opening which will be increased till large enough to expose and remove the cover screw and place the healing abutments.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrosurgical
Description: the monopolar electrosurgical device will be used in the same way as the laser tip with additional care avoiding contacting the implants during exposure.
Study: NCT05359211

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and CSF sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tissue biopsy
Study: NCT06033261

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1608
Description: Sterile liquid for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1608
Description: Sterile liquid for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1608
Description: Sterile liquid for injection

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: BEXSERO
Description: A vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B.
Study: NCT05612217

Intervention type: OTHER
Intervention: to estimate Sensitivity and Specificity AIVARIX app in detecting C1 and C2 classes of CVD
Description: to estimate Sensitivity and Specificity of the AI-based AIVARIX app in detecting C1 and C2 classes of CVD in patients who are seeking for professional advice from a phlebologist regarding symptoms and signs suggestive to CVD.
Study: NCT04854070

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IVUS
Description: IVUS-guided approach in patients with complex coronary lesions undergoing PCI

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Angio
Description: Angio-guided approach in patients with complex coronary lesions undergoing PCI
Study: NCT05459337

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MuST AKT
Description: A behavioural intervention designed to help participants identify and communicate with their social network about living kidney donation.
Study: NCT06460454

Intervention type: DEVICE
Intervention: PET scan of 18F-FDG
Description: VEREOS PET scanner. Philips VEREOS digital PET-CT scanners are installed in the nuclear medicine department.
Study: NCT04283435

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil Citrate
Description: Sildenafil Citrate 50 mg tablets taken from the first day of the cycle till the day we start progesterone (we stop 3 days before embryo transfer)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet (multivitamins),Pregnacare vitamins (Vitabiotics,UK)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol Valerate
Description: Estradiol valerate tablets 2mg every 8 hours daily starting from the fist day of the cycle till 12th day of the menstrual cycle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Estradiol Valerate
Description: Estradiol valerate tablets 2mg every 8 hours daily starting from the fist day of the cycle till 12th day of the menstrual cycle.
Study: NCT05171270

Intervention type: OTHER
Intervention: Questionnaire
Description: PsAID questionnaire
Study: NCT05385341

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (Tele RCV)
Description: 20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training associated with educative sessions.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation (RCV)
Description: 20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.
Study: NCT06136260

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CommunityRx-Bereavement
Description: The medical examiner or coroner will refer parents to an organization called Missing Pieces. Missing Pieces does not deliver healthcare services to grieving families; rather, Missing Pieces helps families find grief services in their community.~For CRx-B, a Grief Navigator from Missing Pieces will text and/or call the parent after receiving the referral; share information about grief and support resources; learn what resources the parent needs for themselves and their family; send the parent a personalized list of grief and social support community resources called a HealtheRx via text, email, or mail; and plan future text message communications with bidirectional functionality and, if requested, subsequent calls or texts from the Grief Navigator to occur at least 3, 6, and 12 months after the child's death.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General Bereavement Support Information
Description: The medical examiner or coroner will refer parents to an organization called Missing Pieces. Missing Pieces does not deliver healthcare services to grieving families; rather, Missing Pieces helps families find grief services in their community.~For GBSI, Missing Pieces sends parents a unidirectional text message providing a link to a webpage with a general list of grief resources (e.g., support groups) and information about grief and bereavement within two weeks of the child's death and again 3, 6, and 12 months after the child's death.
Study: NCT05777837

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic repair of cesarean scar niche
Description: Intentional perforation of the niche will be done using uterine sound and excision of the fibrotic edges then suturing the uterine incision using 2-0 absorbable suture.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined hysteroscopic and laparoscopic repair of cesarean scar niche
Description: Hysteroscopic resection of the niche under laparoscopic guide will be done to avoid perforation of the niche. After completion of the hysteroscopic approach, laparoscopic plication of the niche without opening it will be done using multiple interrupted 2-0 absorbable suture.
Study: NCT05177068

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fruquintinib + sintilimab + SOX
Description: fruquintinib: 4mg/d, qd po, d1-14, q3w; sintilimab: 200 mg/d, IV d1, q3w; S-1: BSA\<1.25 m2, 40mg twice/day; BSA1.25-1.5m2, 50mg twice/day; BSA≥1.5 m2, 60mg twice/day, po, d1-14, q3w; oxaliplatin: 130mg/m2, ivgtt 2-6h, d1, q3w
Study: NCT05876884

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Celsi Warmer Mattress
Description: The hypothermic neonate will be placed on the Celsi Warmer mattress and a temperature probe will be placed on the neonate to monitor the temperature of the neonate for up to 24 hours of intervention time
Study: NCT05627947

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mitomycin c
Description: Comparing the effect of Mitomycin C versus Cyclosporine after primary pterygium surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mitomycin c
Description: Comparing the effect of Mitomycin C versus Cyclosporine after primary pterygium surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mitomycin c
Description: Comparing the effect of Mitomycin C versus Cyclosporine after primary pterygium surgery
Study: NCT05475899

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Instrument assisted soft tissue mobilization
Description: Application of IASTM on the plantar fascia with 10-15 strokes followed by stretching

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Instrument assisted soft tissue mobilization
Description: Application of IASTM on the plantar fascia with 10-15 strokes followed by stretching
Study: NCT05951036

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low-load Blood Flow Restriction training
Description: Physical therapist will apply the BFR cuffs with 70% of arterial occlusion pressure on the both legs of participants. Then, participants will be asked to perform eccentric trainings (including, double leg squats, split squats, deadlifts, and monster walks) with 30% of repetition maximum.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Low-load Blood Flow Restriction training
Description: Physical therapist will apply the BFR cuffs with 10% of arterial occlusion pressure on the both legs of participants. Then, participants will be asked to perform eccentric trainings (including, double leg squats, split squats, deadlifts, and monster walks) with 30% of repetition maximum.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: High-load Eccentric training
Description: Physical therapist will ask participants to perform eccentric trainings (including, double leg squats, split squats, deadlifts, and monster walks) with 70% of repetition maximum.
Study: NCT05206110

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg IV ketorolac
Description: Patients undergoing LAVH, RARP or TLH will receive half an hour before the end of surgery, 10 mg ketorolac (IV). Also, 10 mg IV ketorolac will be given 8h and 16h after the surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 30 mg IV ketorolac
Description: Patients undergoing LAVH, RARP or TLH will receive half an hour before the end of surgery, 30 mg ketorolac (IV). Also, 30 mg ketorolac will be given 8h and 16h after the surgery
Study: NCT05088681

Intervention type: OTHER
Intervention: Rehabilitation program
Description: The exercise intervention will consist of an individualized prescription of resistance training, balance training and cardiovascular exercises delivered for 20 session, one-hour, two/three times per week.
Study: NCT05314777

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low dose ESWT application
Description: Patients trained for low dose ESWT application.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High dose ESWT application
Description: Patients trained for high dose ESWT application.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sham ESWT
Description: Patients trained for sham ESWT.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Training
Description: Patients trained for exercise training.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: Patients trained for exercise training.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: Patients trained for exercise training.
Study: NCT06639997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5148
Description: Participants will receive AZD5148 as IM injection or IV bolus
Study: NCT05195216

Intervention type: BEHAVIORAL
Intervention: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form
Description: Online questionnaires were administered to individuals.

Intervention type: BEHAVIORAL
Intervention: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form
Description: Online questionnaires were administered to individuals.